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1. Introduction 
An earlier eport [1] described preparations of pro- 
teolipid fractions at -60  ° C from quenched rat cerebral 
cortex using column chromatography. When the pro- 
teolipids, after precipitation from the extract by dieth- 
yl ether, were incubated with a particular cholinergic 
substance, this substance was eluted in coincident peaks 
with specific proteolipid fractions. In elution with chlo- 
roform, the first peak of acetylcholine appeared in coin- 
cidence only with the second proteolipid peak and 
that of dimethyltubocurarine (or decamethonium) 
with the first. 
We shall now discuss results obtained when these 
proteolipid fractions dissolved separately or together 
in chloromorm-methanol (2:1 v/v) at room rempera- 
ture were introduced in the biphasic system resul- 
ting when the above organic solutions were mixed 
with aqueous olutions containing the individual 
cholinergic substances. In the absence of proteoli- 
pids these substances remain almost entirely in the 
aqueous phase but in their presence, depending on 
the proteolipid fraction, they are shifted into the 
organic phase in response to binding. Such a distri- 
bution method had been used by Weber et al. [2] 
with a fluorescent cholinergic drug together with pro- 
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teolipid fractions prepared at room temperature when 
no resolution had been observed between fractions 
binding acetylcholine and dimethyltubocurarine (or 
decamethonium). Changes in fluorescence intensities 
had reflected the shift in concentrations of the drug. 
In the present experiments he concentration changes 
in the two phases were followed by scintillation coun- 
ting of the radioactively tagged cholinergic substances. 
This analytical procedure was applied also to three 
phospholipids in place of the proteolipids. 
2. Materials and methods 
Total proteolipids of the extract in the form of the 
dried ether precipitate were warmed to 0°C, dissolved 
in chloroform-methanol (2:1 v/v) and diluted by the 
same solvent o the appropriate sequential concentra- 
tions of fig. 1, expressed as /ag protein (absorption at 
280 nm) per 3 ml of solvent mixture. To the 3 ml was 
added at 0 ° C 1 ml aqueous olution (2 X 10 -s M) 
acetyl-l-14 C choline iodide, decamethonium 1, 10 -14C 
diiodide or dimethyl X4C-d-tubocurarine dichloride 
(all from New England Nuclear, Boston, Massa- 
chusetts). The tubes were shaken vigorously using Vor- 
tex mixer for 2 min at room temperature and centri- 
fuged to get a clear separation of upper aqueous (2 ml) 
and lower organic- phases (2 ml). The radioactivities 
of the phases were estimated by a standard liquid 
scintillation method. 
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Fig. 1. The bindings of radioactive acetylcholine (ACh), 
dimethyltubocurarine (DMTC), decamethonium (C-10) 
to proteolipids from rat cerebral cortex. 
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Fig. 2. Reciprocal inhibition to the binding by radioactive 
cholinergic substances to unchromatographed proteolipids 
in the organic phase. (o) Dimethy1-1 *C tubocurarine + 
nonradioactive acetylcholine. (o ) 14 C-acety[choline +non- 
radioactive dimethyltubocurarine. 100%: 14 C-acetylcholine, 
0.71 × 10 -~ moles; Dimethyl-~4C tubocurarine, 
1.34 × 10 -s moles. 
The proteolipid fractions were each similarly dis- 
solved in chloroform-methanol  (2:1 v/v), brought o 
the appropriate concentrations and treated in the 
same way as the total lipids from which they had been 
fractionated. 
For experiments on reciprocal inhibition to bin- 
ding (fig. 2), ether precipitates of proteolipids dried 
completely by evaporation at -60°C under high va- 
cuum were warmed to ice temperature and dissol- 
ved in the chloroform-methanol  mixture to form a :E 
solution containing 45/ag proteolipid per ml. Two 
ml of this solution were mixed at ice temperature g 
with 1 ml of the chloroform-methanol  containing 
non-radioactive acetylcholine or dimethyltubocura- 
rine and kept at this temperature 5 min before using. 
The concentrations of non-radioactive materials were 
expressed in the figure as the concentration i the 
3 ml of  chloroform-methanol  mixture. One ml aqueous 
solution of ~4C-acetylcholine (2 X 10 -s M) was 
added to the tubes containing non-radioactive dime- 
thyltubocurarine and similarly dimethyl-~4C-tubocu- 
rarine (2 × 10 -s M) was added to that containing 
non-radioactive acetylcholine. Subsequent procedures 
were the same as given for fig. 1. 
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Fig. 3. The bindings of radioactive acetylcholine (ACh), 
dimethyltubocurarine (DMTC)and decamethonium (C-10) 
to phospholipids from bovine brain. 
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For fig. 3 phosphatidyl serine (and also phospha- 
tidyl ethanolamine) of high purity had been freshly 
prepared by Applied Science Laboratories (State Col- 
lege, Pennsylvania) and similarly monophosphatidyl 
inositol by General Biochemicals (Chagrin Falls, Ohio). 
These phospholipids were dissolved in the chloroform- 
methanol mixture and diluted to the desired concen- 
trations. The subsequent operations were the same as 
given above for the proteolipids. 
3. Results 
Fig. 1 represents the concentrations in the biphasic 
system of three cholinergic substances in the organic 
phase (in which they are only slightly soluble in the 
control) as a function of the concentrations of unchro- 
matographed proteolipids introduced into this phase. 
The saturation values of binding of dimethyltubocu- 
rarine and of decamethonium are higher than that of 
acetylcholine and their initial slopes are steeper. The 
proteolipid fractions were tested in the same way for 
binding in biphasic distributions. Bindings to different 
proteolipid fractions by acetylcholine and by the block. 
ing agents made evident at -60°C were confirmed at 
room temperature with some loss, however, in speci- 
ficity by acetylcholine in that it was bound in addi- 
tion to the second proteolipid peak also to the pro- 
teolipid fraction of the first peak but to a lesser 
extent. 
Fig. 2 makes evident he disparity in the recipro- 
cal inhibitions of acetylcholine and dimethyltubocu- 
ratine in their bindings to proteolipids. Clearly the 
inhibition by dimethyltubocurarine against binding 
by acetylene is much stronger than the reverse inhi- 
bition. 
Fig. 3 represents the affinities of cholinergic sub- 
stances for phosphatidyl serine (PS) and for mono- 
phosphatidyl inositol (PI). The saturation concentra- 
tion of acetylcholine induced by the presence of 
phosphatidyl inositol in the organic phase is about 
twice that induced by phosphatidyl serine. The bind- 
ing of acetylcholine has actually not reached satura- 
tion at the highest concentration of the phosphatidyl 
serine of the figure. The initial slope of the curve for 
acetylcholine in the presence of phosphatidyl inositol 
is higher than in the presence of phosphatidyl serine. 
The affinities of dimethyltubocurarine and of decame- 
thonium for both these phospholipids seem about 
equal and greater than the affinities for acetylcholine. 
Similar biphasic analyses proved that dimethyltubocu- 
rarine had but slight affinity for phosphatidyl ethano- 
lamine and acetylcholine had virtually none. 
4. Discussion 
A proper analysis of strengths of binding of the un- 
chromatized proteolipids of fig. 1 reqmres ubstantial- 
ly nrore measurements than we have made (see Weber 
et al. [2] ). From the steeper slope at the origin comes 
the suggestion that the blocking agents bind more 
tightly at their most tightly bound site, (if the site next 
in tightness is considerably weaker) than does acetyl- 
choline to a corresponding site. Further suggestion of 
this is shown (fig. 2) in the greater inhibition by 
dimethyltubocurarine against he binding by acetyl- 
choline than the reciprocal inhibition, acetylcholine 
against dimethyltubocurarine. 
We may consider two factors that would induce 
loss in the specificity of binding by acetylcholine 
at room temperature as compared with that at -60°C. 
(1) The organic solvents used at the higher tempera- 
ture may have modified tile conformation of the pro- 
teolipids of tire first fraction and dissociated off some 
of their lipid components or exchanged some with 
others in tim extract [3]. On the other hand, the spe- 
cificity observed at -60°C was of proteolipids whose 
highest emperature of contact with chloroform-metha- 
nol was 60°C. It had originated in rat cerebral cortex 
quenched to -195°C and warmed to -60°C for extrac- 
tion and fractionation. (2) The conformation of the 
first fraction of proteolipids had been modified by its 
contact with water in the biphasic distribution and the 
water may have brought new attracting roups to the 
surface of the proteolipid. 
Another factor differentiates the preparation of 
-60°C and of room temperature, namely their diffe- 
rent populations of proteolipids. In the extraction at 
-60°C a fraction of the proteolipids in the tissue dis- 
sociated off upon extraction, that on the average had 
weaker bonds with the residue than that requiring 
higher temperatures for extraction. Extraction at suc- 
cessively higher temperatures suggests itself for future 
work. 
Phospholipids are known to be components of the 
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proteolipids. Phosphatidyl inositol [4] and probably 
phosphatidyl serine are among them. Although with- 
out specificity for binding when free, they would be 
expected if within the active binding sites of the pro- 
teolipids to contribute to the specificity as well as to 
the strength of binding with cholinergic substances. 
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